Mice expressing Shp2D61Y do not usually succumb to leukemia until 45 weeks after induction of expression [9] and mice with Dnmt3a haploinsufficiency do not develop disease until approximately 80 weeks [8]. This evidence concerns the gene DNMT3A and leukemia.